STEPHANIE FIELDS: Open Payments
NPI 1518307560 · WINCHESTER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,600 in 134 payments from 21 companies in 2025. Trend: 2023 $2,719 · 2024 $2,543 · 2025 $2,600
Food & beverage: $2,600
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 31 | $511 |
| AstraZeneca Pharmaceuticals LP | 16 | $335 |
| Insmed, Inc. | 15 | $323 |
| GENZYME CORPORATION | 12 | $232 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $194 |
| Grifols USA, LLC | 10 | $179 |
| Viatris Specialty LLC | 7 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $130 |
| Amgen Inc. | 5 | $122 |
| Verona Pharma, Inc. | 6 | $105 |
Products named: Arikayce, TEZSPIRE, NUCALA, DUPIXENT, TRELEGY ELLIPTA, Prolastin-C Liquid, YUPELRI, Ohtuvayre.
Industry payments across KY — which companies pay providers there.
